Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6887-6897

  Nonkwelo, Carol ^a   Ruf, Ingrid K ^a   Sample, Jeffery ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; PROTEIN EBNA 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IRF 1; TRANSCRIPTION FACTOR IRF 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BURKITT LYMPHOMA; DAUDI CELL; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE REPRESSION; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0030816194     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.6887-6897.1997     Document Type: Article

References (62)

1. Au, W., P. A. Moore, W. Louther, Y. Juang, and P. Pitha. 1995. Identification of a member of the Interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 82:11657-11661.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1989. Current protocols in molecular biology. John Wiley and Sons, Inc., New York, N.Y.
3. Bodescot, M., M. Perricaudet, and P. Farrell. 1987. A promoter for the highly spliced EBNA family of RNAs of Epstcin-Barr virus. J. Virol. 61: 3424-3430.
4. Bovolenta, A., P. H. Driggers, M. S. Marks, J. A. Medin, A. D. Politis, S. N. Vogel, D. E. Levy, K. Sakaguchi, E. Apella. J. E. Coligan, and K. Ozato. 1994. Molecular interactions between Interferon consensus sequence binding protein and members of the Interferon regulatory factor family. Proc. Natl. Acad. Sci. USA 91:5040-5050.
5. Brass, A. L., E. Kehrli, C. F. Eisenbeis, U. Storb, and H. Singh. 1996. Pip, a lymphoid-rcstricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the ets factor PU.l. Genes Dev. 10:2335-2347.
6. Chen, C. L., R. H. Sadler, D. M. Walling, I. J. Su, H. C. Hsieh, and N. Raab-Traub. 1993. Epstcin-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J. Virol. 67:6303-6308.
7. Chen, F., J.-Z. Zou, L. di Renzo, G. Winherg, L.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:3752-3758.
8. Cohen, B., D. Peretz, D. Vaiman, P. Benech, and J. Chebath. 1988. Enhancer-like interferon responsive sequences of the human and murine (2′-5′) oligoadenylate synthetase gene promoters. EMBO J. 7:1411-1419.
9. Darnell, J. E., I. M. Kerr, and G. R. Stark. 1994. Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
10. Deacon, E. M., G. Pallesen, G. Niedobitek, J. Crocker, L. Brooks, A. B. Rickinson, and L. S, Young. 1993. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177:339-349.
11. Fahraeus, R., H. Li-Fu, I. Ernberg, J. Finke, M. Rowe, G. Klein, K. Falk, E. Nilsson, M. Yadaf, P. Busson, T. Tursz, and B. Kallin. 1988. Expression of the Epstein-Barr virus genome in nasopharyngeal carcinoma. Int. J. Cancer 42:329-338.
12. Fries, K. L., T. B. Sculley. J. Webster-Cyriaque, P. Rajadurai, R. H. Sadler, and N. Raab-Traub. 1997. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J. Virol. 71:2765-2771.
13. Grossman, A., J. Nicholl, L. Antonio, R. Luethy, S. Suggs, G. R. Sutherland, and T. Mak. 1996. Characterization of IRF7, a novel Interferon regulatory factor. Unpublished data.
14. Hiscott, J., H. Nguyen, and R. Lin. 1995. Molecular mechanisms of inter-feron beta gene induction. Semin. Virol. 6:161-173.
15. Hummel, M., and E. Kieff. 1982. Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells. J. Virol. 43:262-272.
16. Ihle, J. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-334.
17. Jansson, A., M. Masucci, and L. Rymo. 1992. Methylation of discrete sites within the enhancer region regulates the activity pf the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines. J. Virol. 66:62-69.
18. Khanna, R., S. R. Burrows, M. G. Kurilla, C. A. Jacob, I. S. Misko, T. B. Sculley, E. Kieff, and D. J. Moss. 1992. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recomninant vaccinia: implications for vaccine development. J. Exp. Med. 176:169-176.
19. Khanna, R., S. R. Burrows, P. M. Steigerwald-Mullen, S. A. Thomson, M. G. Kurilla, and D. J. Moss. 1995. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptidc epitopcs from EpsteinBarr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. Virology 214:633-637.
20. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
21. Li, J. J., and I. Herskowitz. 1993. Isolation of ORC6, a component of the yeast origin recognition complex by a one-hybrid system. Science 262:1870-1874.
22. Minarovits, J., L.-F. Hu, S. Minarovits-Kormuta, G. Klein, and I, Ernberg. 1994. Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP-1 and BCR2 enhancer promoter regions. Virology 200:661-667.
23. Murray, R., M. Kurilla, J. Brooks, W. Thomas, M. Rowe, E. Kieff, and A. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV positive malignancies. J. Exp. Med. 176:157-168.
24. Nonkwelo, C., E. B. D. Henson, and J. Sample. 1995. Characterization of the Epstein-Barr virus Fp promoter. Virology 206:183-195.
25. Nonkwelo, C., I. K. Ruf, and J. Sample. 1997. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like clement. J. Virol. 71:354-361.
26. Nonkwelo, C., J. Skinner, A. Bell, A. Rickinson, and J. Sample. 1996. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol. 70:623-627.
27. Pallesen, G., S. J. Hamilton-Dutoit, M. Rowe, and L. S. Young. 1991. Expression of the Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 337:320-322.
28. Palomhella, V. J., and T. Maniatis. 1992. Inducible processing of Interferon regulatory factor-2. Mol. Cell. Biol. 12:3325-3336.
29. Pitha, P. M., and W. Au. 1995. Induction of interferon alpha genes expression. Semin. Virol. 6:151-159.
30. Rawlins, D. R., G. Milman, S. D. Hayward, and G. S. Hayward. 1985. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859-868.
31. Robertson, K. D., S. D. Hayward, P. D. Ling, D. Samid, and R. F. Amhinder. 1995. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol. Cell. Biol. 15:6150-6159.
32. Rooney, C., M. Rowe, L. Wallace, and A. Rickinson. 1985. Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance. Nature 317:629-631.
33. Rowe, D., M. Rowe, G. Evan, L. Wallace, P. Farrell, and A. Rickinson. 1986. Restricted expression of EBV latent genes and T-lymphocyte-dctected membrane antigen in Burkitt's lymphoma cells. EMBO J. 5:2599-2607.
34. 33a.Sample, J. Unpublished data.
35. Sample, J., E. B. D. Henson, and C. Sample. 1992. The Epstcin-Barr virus nuclear protein 1 promoter active in type 1 latency is autoregulated. J. Virol. 66:4654-4661.
36. Sample, J., M. Hummel, D. Braun, M. Birkenbach, and E. Kieff. 1986. Nuclcotide sequences of messenger RNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc. Natl. Acad. Sci. USA 83:5096-5100.
37. Sample, J., and E. Kieff. 1990. Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes. J. Virol. 64:1667-1674.
38. Schaefer, B. C., E. Paulson, J. L. Strominger, and S. H. Speck. 1997. Constitutive' activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol. Cell. Biol. 17:873-886.
39. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J. Virol. 69:5039-5047.
40. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92:10565-10569.
41. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1997. Host cell-determined methylation of specific Epstcin-Barr virus promoters regulates the choice between distinct viral latency programs. Mol. Cell. Biol. 17:364-377.
42. Selden, R. F., K. B. Howie, M. E. Rowe, H. M. Goodman, and D. D. Moore. 1986. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6:3173-3179.
43. Smith, P., and B. Griffin. 1991. Differential expression of Epstein-Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells. Nucleic Acids Res. 19:2435-2440.
44. Smith, P. R., and B. E. Griffin. 1992. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngcal carcinoma and B-lymphoblastoid cells. J. Virol. 66:706-714.
45. Sung, N. S., J. Wilson, M. Davenport, N. D. Sista, and J. S. Pagano. 1994. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol. Cell. Biol. 14:7144-7152.
46. Tanaka, N., M. Ishihara, M. Kitagawa, H. Harada, T. Kimura, T. Matsuyama, M. S. Lamphier, S. Aizawa. T. W. Mak, and T. Taniguchi. 1994. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77:829-839.
47. Tanaka, N., T. Kawakami, and T. Taniguchi. 1993. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:4531-4538.
48. Taniguchi, T., Harada, H., and M. Lamphier. 1995. Regulation of the interferon system and cell growth by the IRF transcription factors. J. Cancer Res. Clin. Oncol. 121:516-520.
49. Thorley-Lawson, D. A., E. M. Miyashita, and G. Khan. 1996. Epstcin-Barr virus and the B cell: that's all it takes. Trends Microbiol. 4:204-208.
50. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstcin-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
51. Usheva, A., and T. Shenk. 1994. TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymcrase II direct basal transcription on supercoiled template DNA. Cell 76:1115-1121.
52. Vaughan, P. S., F. Aziz, A. J. van Wijnen, S. Wu, H. Harada, T. Taniguchi, K. J. Soprano, J. L. Stein, and G. S. Stein. 1995. Activation of a cell-cycle-regulatcd historic gone by the oncogenic transcription factor IRF-2. Nature 377:362-365.
53. Veals, S. A., C. Schlndler, D. Leonard, X.-Y. Fu, R. Aebersold, J. E. Darnell, Jr., and D. E. Levy. 1992. Subunit of an alpha-interferon-rcsponsive transcription factor is related to Interferon regulatory factor and Myb families of DNA-binding proteins, Mol. Cell. Biol. 12:3315-3324.
54. Wang, I., J. C. G. Blanco, S. Y. Tsai, M. Tsai, and K. Ozato. 1996. Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro. Mol. Cell. Biol. 16:6313-6324.
55. Watanabe, N., J. Sakakibara, A. G. Hovanessian, T. Taniguchi, and T. Fujita. 1991. Activation of IFN-β clement by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acids Res. 19:4421-4428.
56. Weisz, A., P. Marx, R. Sharf, E. Appella, P. H. Driggers, K. Ozato, and B. Levi. 1992. Human Interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem. 267:25589-25596.
57. Woisetschlaeger, M., C. N. Yandava, L. A. Furmanski, J. L. Strominger, and S. H. Speck. 1990. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA 87:1725-1729.
58. Yamagata, T., J. Nishida, T. Tanaka, R. Sakai, K. Mitani, M. Yoshida, T. Taniguchi, Y. Yazaki, and H. Hirai. 1996. A novel Interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulutcd genes. Mol. Cell. Biol. 16:1283-1294.
59. Yamamoto, H., M. S. Lamphier, T. Fujita, T. Taniguchi, and H. Harada. 1994. The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain. Oncogene 9:1423-1428.
60. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815.
61. Young, L., C. Dawson, D. Clark, H. Rupani, P. Busson, T. Tursz, A. Johnson, and A. Rickinson. 1988. Epstein-Barr virus gene expression in nasopharyngual carcinoma. J. Gen. Virol. 69:1051-1065.
62. Zhang, L., and J. S. Pagano. IRF-7, a new Interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell. Biol., in press.